paper-with-me

홈 › Papers

Joint Treatment Effect Estimation from Incomplete Healthcare Data: Temporal Causal Normalizing Flows with LLM-driven Evolutionary MNAR Imputation

2026-05-06 · Olivia Jullian Parra, Sara Zoccheddu, David Catalan Cerezo, Tom Forzy, Franziska Ulrich, William Sutcliffe, Jakob Martin Burgstaller, Oliver Senn, Patrick Owen, Nicola Serra arxiv

Target trial emulation (TTE) enables causal questions to be studied with observational data when randomized controlled trials (RCTs) are infeasible. Yet treatment-effect methods often address causal estimation, missingness, and temporal structure separately, limiting their robustness in electronic health records (EHRs), where time-varying confounding and missing-not-at-random (MNAR) biomarkers can reach 50%--80%. We propose a two-stage pipeline for treatment effect estimation from incomplete longitudinal EHRs. First, CausalFlow-T, a directed acyclic graph (DAG)-constrained normalizing flow with long short-term memory (LSTM)-encoded patient history, performs exact invertible counterfactual inference, avoiding approximation errors from variational inference and separating confounding through explicit causal structure. Ablations on four synthetic and one semi-synthetic benchmark with known counterfactuals show that DAG constraints and exact inference address distinct failure modes: neither compensates for the other. Second, because CausalFlow-T requires completed inputs, we introduce an LLM-driven evolutionary imputer that proposes executable imputation operators rather than individual entries, and evaluate it with three large language model (LLM) backends, including two open-source models. Across 30%--80% MNAR missingness, this imputer achieves the best pooled rank over biomarker and causal metrics, leading in point-wise accuracy and temporal extrapolation while preserving average treatment effect (ATE) recovery as statistical baselines degrade. On Swiss primary-care EHRs from adults with type 2 diabetes initiating a GLP-1 receptor agonist or SGLT-2 inhibitor, the pipeline estimates a per-protocol weight-loss difference of -0.98 kg [95% CI -1.01, -0.96] favoring GLP-1 receptor agonists, consistent with randomized evidence and obtained from realistically incomplete real-world EHRs.

📄 PDF Abstract BibTeX arXiv:2605.05125

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Copula-Based Endogeneity Correction for Doubly Robust Estimation of Treatment Effect

2026-05-05 · Sahil Shikalgar, Md. Noor-E-Alam arxiv

Doubly Robust (DR) estimation of treatment effect relies on an untestable assumption that is the absence of unobserved confounding. This assumption is par- ticularly problematic in the context of healthcare research, whe…

Estimation of Local Average Treatment Effect by Data Combination

2021-09-11 · Kazuhiko Shinoda, Takahiro Hoshino

It is important to estimate the local average treatment effect (LATE) when compliance with a treatment assignment is incomplete. The previously proposed methods for LATE estimation required all relevant variables to be j…

Model Selection

NCoRE: Neural Counterfactual Representation Learning for Combinations of Treatments

2021-03-20 · Sonali Parbhoo, Stefan Bauer, Patrick Schwab

Estimating an individual's potential response to interventions from observational data is of high practical relevance for many domains, such as healthcare, public policy or economics. In this setting, it is often the cas…

counterfactualCounterfactual InferenceRepresentation Learning

Dynamic Inter-treatment Information Sharing for Individualized Treatment Effects Estimation

2023-05-25 · Vinod Kumar Chauhan, Jiandong Zhou, Ghadeer Ghosheh, Soheila Molaei 외

Estimation of individualized treatment effects (ITE) from observational studies is a fundamental problem in causal inference and holds significant importance across domains, including healthcare. However, limited observa…

Causal InferencecounterfactualCounterfactual Inference

Differentially Private Multi-Site Treatment Effect Estimation

2023-10-10 · Tatsuki Koga, Kamalika Chaudhuri, David Page

Patient privacy is a major barrier to healthcare AI. For confidentiality reasons, most patient data remains in silo in separate hospitals, preventing the design of data-driven healthcare AI systems that need large volume…

Causal InferenceFederated Learning